मुख्य सामग्री पर जाएं
PrEP

एचआईवी रोकथाम दवा प्रेप किसे लेनी चाहिए?

पूर्व-संपर्क प्रोफिलैक्सिस (PrEP) एक दवा है जो HIV के विकास को रोकने के लिए होती है। यह उन लोगों के लिए है जिनके पास HIV नहीं है, लेकिन उन्हें इस स्थिति के विकसित होने की उच्च संभावना है। लेकिन यह क्या है, यह कैसे काम करता है और किसे इसका उपयोग करना चाहिए?

के लिए वीडियो चयन HIV and AIDS

नीचे पढ़ना जारी रखें

What is PrEP and how does it prevent HIV?

PrEP is a medication that prevents HIV transmission. When taken as prescribed - usually a pill taken daily - it’s almost 100% effective. It works by helping the body to produce antibodies which prevent HIV from replicating inside the body. Essentially, the drug stops the virus from crossing into the healthy cells and reproducing.

While it's possible to take so-called 'events-based PrEP' - when you take it as and when needed - daily dosing is generally considered more reliable.

Different PrEP delivery methods such as injectables and implants are also being researched. In 2021, the World Health Organisation recommended a new option called the vaginal ring for women at substantial risk of HIV acquisition1.

Adam Freedman, senior policy and campaigns officer at the National AIDS Trust, says anyone who feels at risk of getting HIV could consider taking PrEP. It may be suitable for you if you are HIV negative or have sex in a variety of situations where condoms are not easily or always used.

"That said, there are higher rates of HIV among certain demographics, including gay and bisexual and other men who have sex with men, migrants, Black Africans, Black Caribbeans, and transgender people," he says. "Uptake of PrEP has been higher among white gay and bisexual men, which has led to a corresponding drop in new diagnoses," Freedman adds.

"However, uptake has been much lower among other groups. That’s why it’s so important to make PrEP more accessible for everyone who needs it."

Evidence from the UK PROUD study reported that PrEP reduced the risk of HIV infection by 86% for men who have sex with men2. In 2021, however, NICE recommended promoting PrEP to several higher-risk groups, including HIV negative men who have condomless sex with other men and HIV-negative heterosexual men and women having condomless sex with partners who are HIV positive. It also suggested promoting PrEP among HIV-negative trans women at elevated risk of developing HIV through condomless sex3.

नीचे पढ़ना जारी रखें

PrEP is available for free from sexual health clinics in England, Scotland, Wales and Northern Ireland.

"PrEP is available on the NHS, meaning everyone has the right to access it. If you want to start taking it, your first port of call should be your local sexual health clinic," says Freedman. "Lots of people choose to buy PrEP on the internet, which, while legal and typically safe, can be expensive. As we see it, no one should be forced to pay over-the-odds for a treatment which they’re legally entitled to receive from the NHS."

The UK Government pledged to end new cases of HIV infection by 2030, by scaling up HIV testing and increasing access to PrEP among at-risk communities. However, researchers have warned this ambition may be under threat because access to PrEP in England is far lower than it should be.

Of 1,120 people who tried to get an appointment to get PrEP between October 2021 and July 2022, around two-thirds (68%) encountered problems. More than one third (35%) waited 12 weeks to be seen, and 57% waited more than 12 weeks4. Long waiting times, lack of appointments, and a training shortfall are all part of the problem, made worse by the कोविड-19 pandemic and funding cuts5.

If you need PrEP or would like more information about it, it’s important to go to your sexual health clinic without delay.

नीचे पढ़ना जारी रखें

1. WHO: WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection.

2. UK Proud study: Examining the impact on gay men of Pre-exposure Prophylaxis.

3. NICE: NICE recommends offering PrEP to people at high risk of HIV for first time.

4. BMJ: HIV: Two in three people have trouble getting PrEP, finds survey.

नीचे पढ़ना जारी रखें

लेखक के बारे मेंपूरा जीवन परिचय देखें

लेखक की छवि

Lydia Smith

विशेष लेखक

बीए, एमए, एमएससी

लिडिया स्मिथ एक पुरस्कार विजेता पत्रकार और फीचर लेखिका हैं जिन्होंने महिलाओं के स्वास्थ्य और मानसिक स्वास्थ्य पर व्यापक रूप से लिखा है। वह वर्तमान में मनोविज्ञान में एमएससी की पढ़ाई कर रही हैं।.

समीक्षक के बारे मेंपूरा जीवन परिचय देखें

लेखक की छवि

Dr Krishna Vakharia, MRCGP

स्वास्थ्य के लिए मुख्य चिकित्सा अधिकारी, ऑप्टम यूके

MBChB, MRCGP(2013), BMedSci (hons), DFSRH, DRCOG, PGDipDerm (Distn)

डॉ. कृष्णा वखारिया एक एनएचएस जीपी हैं। वह कार्डिफ विश्वविद्यालय में प्रैक्टिकल डर्मेटोलॉजी में स्नातकोत्तर डिप्लोमा के लिए नियमित परीक्षक भी हैं और साथ ही ऑप्टम यूके में स्वास्थ्य के लिए मुख्य चिकित्सा अधिकारी भी हैं।.

लेख का इतिहास

इस पृष्ठ की जानकारी योग्य चिकित्सकों द्वारा सहकर्मी समीक्षा की गई है।.

  • 13 Jan 2023 | मूल रूप से प्रकाशित

    द्वारा लिखित:

    Lydia Smith

    द्वारा सहकर्मी समीक्षा की गई

    Dr Krishna Vakharia, MRCGP
फ्लू पात्रता जाँचकर्ता

पूछें, साझा करें, जुड़ें।.

चर्चाओं को ब्राउज़ करें, प्रश्न पूछें, और सैकड़ों स्वास्थ्य विषयों पर अनुभव साझा करें।.

लक्षण जाँचकर्ता

अस्वस्थ महसूस कर रहे हैं?

अपने लक्षणों का ऑनलाइन मुफ्त में मूल्यांकन करें

पेशेंट न्यूज़लेटर के लिए साइन अप करें

आपकी साप्ताहिक खुराक स्पष्ट, विश्वसनीय स्वास्थ्य सलाह की - जो आपको सूचित, आत्मविश्वासी और नियंत्रण में महसूस करने में मदद करने के लिए लिखी गई है।.

कृपया एक मान्य ईमेल पता दर्ज करें

सदस्यता लेने पर आप हमारी स्वीकार करते हैं गोपनीयता नीति. आप किसी भी समय सदस्यता समाप्त कर सकते हैं। हम कभी भी आपका डेटा नहीं बेचते।.